US 9062095
Mutant double cyclized receptor peptides inhibiting β1-adrenoceptor antibodies
granted A61KA61K38/00A61P
Quick answer
US patent 9062095 (Mutant double cyclized receptor peptides inhibiting β1-adrenoceptor antibodies) held by Julius-Maximilians-Universitat Wurzburg expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Julius-Maximilians-Universitat Wurzburg
- Grant date
- Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 54
- CPC classes
- A61K, A61K38/00, A61P, A61P29/00, A61P37/06